Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codagenix uses a computer-based algorithm, called SAVE (Synthetic Attenuated Virus Engineering) to design viral genomes that are identical to the wild type strain at the amino acid level, but make less protein in human cells. The highly attenuated viruses make excellent vaccines or oncolytics against solid tumors. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 3 Bioscience Park Dr, Farmingdale,new York 11735,united States
- Phone
- 5168290353
- in****@****nix.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- codagenix.com
- Keywords
- Live-attenuated vaccine design, infectious disease, Synthetic biology, virology, clinical trials, vaccines, influenza, RSV, dengue, oncolytics.
- HQ
- Farmingdale, New York
Codagenix Inc. Questions
Codagenix Inc.'s helpline number is 5168290353
Codagenix Inc.'s website is codagenix.com
Codagenix Inc.'s LinkedIn profile is https://www.linkedin.com/company/codagenix
Codagenix Inc. has
22 employees.
View email and phone details for 22
employees at Codagenix Inc..
Codagenix Inc.'s industry is
Biotechnology Research
Codagenix Inc.'s top competitors are
Hervolution Therapeutics,
Moderna,
Avidity Biosciences, Inc.,
Synklino,
Aelix Therapeutics,
Crispr Qc,
Inventprise,
Loma Therapeutics,
Hydrocision Inc.,
Biocogent Llc.
Codagenix Inc.'s support email address is info@codagenix.com
Codagenix Inc.'s categories are Biotechnology Research
Codagenix Inc.'s founding year is 2011
